Use of activated prothrombin complex concentrate overmultiple surgical episodes in a hemophilic child with an inhibitor
- 30 June 1983
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 102 (6), 951-954
- https://doi.org/10.1016/s0022-3476(83)80032-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Hazards of Prothrombin-Complex Concentrates in Treatment of HemophiliaNew England Journal of Medicine, 1981
- Highly purified porcine factor VIII in haemophilia A with inhibitors to factor VIII.BMJ, 1981
- Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.BMJ, 1980
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980
- Effect of prothrombin complex concentrates on factor VIII inhibitor levelsBlood, 1979
- Effect of Treatment with Activated Prothrombin Complex Concentrate (FEIBA) on Factor VIII-Antibody LevelThrombosis and Haemostasis, 1978
- DISSEMINATED INTRAVASCULAR COAGULATION AND INFUSION OF FACTOR-VIII-INHIBITOR BYPASSING ACTIVITYThe Lancet, 1977
- Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitorsThe Journal of Pediatrics, 1976
- The Treatment of Patients who have Factor-VIII AntibodiesBritish Journal of Haematology, 1973